Modulation of Cellular Function by the Urokinase Receptor Signalling: A Mechanistic View

Modulation of Cellular Function by the Urokinase Receptor Signalling: A Mechanistic View

Urokinase-type plasminogen activator receptor (uPAR or CD87) is a glycosyl-phosphatidyl-inositol anchored (GPI) membrane protein. The uPAR primary ligand is the serine protease urokinase (uPA), converting plasminogen into plasmin, a broad spectrum protease, active on most extracellular matrix compon...

Full description

Bibliographic Details
Main Authors:	Daniela Alfano, Paola Franco, Maria Patrizia Stoppelli
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-04-01
Series:	Frontiers in Cell and Developmental Biology
Subjects:	urokinase receptor cell migration epithelial mesenchyme transition stemness cell differentiation virus infection
Online Access:	https://www.frontiersin.org/articles/10.3389/fcell.2022.818616/full

Similar Items

Therapeutic Strategies Targeting Urokinase and Its Receptor in Cancer
by: Maria Teresa Masucci, et al.
Published: (2022-01-01)

Induction of Urokinase Activity by Retinoic Acid in Two Cell Lines of Neuronal Origin
by: Luka Horvat, et al.
Published: (2019-09-01)

Targeting the cross-talk between Urokinase receptor and Formyl peptide receptor type 1 to prevent invasion and trans-endothelial migration of melanoma cells
by: Concetta Ragone, et al.
Published: (2017-12-01)

Urokinase Receptor and Resistance to Targeted Anticancer Agents
by: Steven L. Gonias, et al.
Published: (2015-07-01)

Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin′s Lymphoma
by: Shirin Kouhpayeh, et al.
Published: (2017-01-01)

The Urokinase Receptor: A Multifunctional Receptor in Cancer Cell Biology. Therapeutic Implications
by: Anna Li Santi, et al.
Published: (2021-04-01)

Preliminary assessment of the possibility of using urokinase uPA and urokinase receptor uPAR as universal diagnostic criteria in patients with colorectal and gastric adenocarcinoma
by: Polina S. Klimovich, et al.
Published: (2021-12-01)

Mesenchymal Stem Cell-Like Properties in Fibroblasts
by: Yuqiao Chang, et al.
Published: (2014-08-01)

TLR4 Response to LPS Is Reinforced by Urokinase Receptor
by: Yulia Kiyan, et al.
Published: (2020-12-01)

Predicting Mortality in African Americans With Type 2 Diabetes Mellitus: Soluble Urokinase Plasminogen Activator Receptor, Coronary Artery Calcium, and High‐Sensitivity C‐Reactive Protein
by: Salim S. Hayek, et al.
Published: (2018-05-01)

Macrophages and Urokinase Plasminogen Activator Receptor System in Multiple Myeloma: Case Series and Literature Review
by: Paola Manzo, et al.
Published: (2023-06-01)

Value of soluble Urokinase plasminogen activator receptor over age as a biomarker of impaired myocardial relaxation
by: Koh, Angela S., et al.
Published: (2018)

Role of ErbB receptors in cancer cell migration and invasion
by: Aline eAppert-Collin, et al.
Published: (2015-11-01)

Communication Between Epithelial–Mesenchymal Plasticity and Cancer Stem Cells: New Insights Into Cancer Progression
by: Xiaobo Zheng, et al.
Published: (2021-04-01)

Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID‐19
by: Shengyuan Luo, et al.
Published: (2022-09-01)

Commentary: Somatic Stem Cells and Their Dysfunction in Endometriosis
by: Ekaterini Christina Tampaki, et al.
Published: (2017-07-01)

Cellular therapy of corneal epithelial defect by adipose mesenchymal stem cell-derived epithelial progenitors
by: Francisco Bandeira, et al.
Published: (2020-01-01)

Role of multidomain structure of urokinase in regulation of growth and remodeling of vessels
by: V. A. Tkachuk, et al.
Published: (2013-12-01)

Elevated PLAUR is observed in the airway epithelium of asthma patients and blocking improves barrier integrity
by: Michael A. Portelli, et al.
Published: (2023-10-01)

Urokinase-type plasminogen activator is a modulator of synaptic plasticity in the central nervous system: implications for neurorepair in the ischemic brain
by: Manuel Yepes
Published: (2020-01-01)

The Contribution of the Urokinase Plasminogen Activator and the Urokinase Receptor to Pleural and Parenchymal Lung Injury and Repair: A Narrative Review
by: Torry A. Tucker, et al.
Published: (2021-02-01)

Inhibition of Urokinase-Type Plasminogen Activator Expression by Macelignan in Porphyromonas gingivalis Supernatant-Induced Human Oral Epithelial Cells
by: YANTI
Published: (2010-03-01)

Inhibition of Urokinase-Type Plasminogen Activator Expression by Macelignan in Porphyromonas gingivalis Supernatant-Induced Human Oral Epithelial Cells
by: YANTI
Published: (2010-03-01)

Role of Vitamin C in Targeting Cancer Stem Cells and Cellular Plasticity
by: Yool Lee
Published: (2023-11-01)

Serum Levels of Urokinase Plasminogen Activator Receptor (suPAR) Discriminate Moderate Uncontrolled from Severe Asthma
by: Ourania S. Kotsiou, et al.
Published: (2022-10-01)

A Novel Estrogen Receptor β Agonist Diminishes Ovarian Cancer Stem Cells via Suppressing the Epithelial-to-Mesenchymal Transition
by: Ananya Banerjee, et al.
Published: (2022-05-01)

The Prognostic Significance of Soluble Urokinase Plasminogen Activator Receptor in Acute Myeloid Leukemia
by: Nergiz Erkut, et al.
Published: (2016-05-01)

Monitoring of chemotherapy successfulness of Platina/Taxol chemotherapy protocol by using determination of serum urokinase plasminogen activator (uPA) and soluble urokinase plasminogen activator receptor (suPAR) in patients with ovarian carcinoma FIGO II
by: Dženita Ljuca, et al.
Published: (2007-05-01)

Mitochondria Lead the Way: Mitochondrial Dynamics and Function in Cellular Movements in Development and Disease
by: Somya Madan, et al.
Published: (2022-02-01)

Soluble urokinase plasminogen activator receptor and its complicated role in hemodialysis (HD) patients with Covid-19 infection
by: Ioannis Griveas, et al.
Published: (2021-07-01)

Constructing interactive networks of functional genes and metabolites to uncover the cellular events related to colorectal cancer cell migration induced by arsenite
by: Ruijia Zhang, et al.
Published: (2023-04-01)

Soluble Urokinase Plasminogen Activator Receptor (suPAR) in the Emergency Department (Ed): A Tool for the Assessment of Elderly Patients
by: Ria M. Holstein, et al.
Published: (2022-06-01)

Cellular dynamics of EMT: lessons from live in vivo imaging of embryonic development
by: Jeffrey D. Amack
Published: (2021-07-01)

Microenvironmental Signals and Biochemical Information Processing: Cooperative Determinants of Intratumoral Plasticity and Heterogeneity
by: Alexander E. Davies, et al.
Published: (2018-04-01)

Urokinase System in Pathogenesis of Pulmonary Fibrosis: A Hidden Threat of COVID-19
by: Anna A. Shmakova, et al.
Published: (2023-01-01)

Association between serum soluble urokinase-type plasminogen activator receptor and atrial fibrillation
by: Noboru Ichihara, et al.
Published: (2017-10-01)

The role of epithelial cells in fibrosis: Mechanisms and treatment
by: Liuyi Luo, et al.
Published: (2024-04-01)

Hybrid E/M Phenotype(s) and Stemness: A Mechanistic Connection Embedded in Network Topology
by: Satwik Pasani, et al.
Published: (2020-12-01)

Cleavage of the urokinase receptor (uPAR) on oral cancer cells: regulation by transforming growth factor – β1 (TGF-β1) and potential effects on migration and invasion
by: Synnove Norvoll Magnussen, et al.
Published: (2017-05-01)

From Tissue Physoxia to Cancer Hypoxia, Cost-Effective Methods to Study Tissue-Specific O<sub>2</sub> Levels in Cellular Biology
by: Carlos H. V. Nascimento-Filho, et al.
Published: (2022-05-01)